---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-011013"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2024-02-05T23:59:59+00:00"
generated_at: "2026-06-06T09:10:02.375077+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Corbus Pharmaceuticals updates investor presentation; no material changes disclosed

## Summary
- Filed updated corporate presentation dated February 2, 2024, as Exhibit 99.1.
- Presentation title slide only provided; no specific operational or financial updates included.
- No new drug pipeline milestones, financial results, or strategic changes announced.
- Routine disclosure under Regulation FD; presentation available on company website.

## SEC filing metadata
- accession: 0000950170-24-011013
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2024-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017024011013/0000950170-24-011013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017024011013/crbp-20240205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-011013
- JSON: https://secwatch.observer/filing/0000950170-24-011013.json
- Plain text: https://secwatch.observer/filing/0000950170-24-011013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.